Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 3194917, 10 pages
https://doi.org/10.1155/2018/3194917
Research Article

Deletion of NAD(P)H Oxidase 2 Prevents Angiotensin II-Induced Skeletal Muscle Atrophy

1Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan
2Graduate School of Lifelong Sport, Hokusho University, 23 Bunkyodai, Ebetsu, Hokkaido 069-8511, Japan

Correspondence should be addressed to Shintaro Kinugawa; pj.ca.iadukoh.dem@eohakcut

Received 1 September 2017; Revised 1 December 2017; Accepted 12 December 2017; Published 2 January 2018

Academic Editor: Ken-ichi Aihara

Copyright © 2018 Tomoyasu Kadoguchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Cruz-Jentoft, J. P. Baeyens, J. M. Bauer et al., “Sarcopenia: european consensus on definition and diagnosis: report of the european working group on sarcopenia in older people,” Age and Ageing, vol. 39, no. 4, Article ID afq034, pp. 412–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Braun and M. Gautel, “Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis,” Nature Reviews Molecular Cell Biology, vol. 12, no. 6, pp. 349–361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Glass, “Signalling pathways that mediate skeletal muscle hypertrophy and atrophy,” Nature Cell Biology, vol. 5, no. 2, pp. 87–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Viña, A. Salvador-Pascual, F. J. Tarazona-Santabalbina, L. Rodriguez-Mañas, and M. C. Gomez-Cabrera, “Exercise training as a drug to treat age associated frailty,” Free Radical Biology & Medicine, vol. 98, pp. 159–164, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Kinugawa, S. Takada, S. Matsushima, K. Okita, and H. Tsutsui, “Skeletal muscle abnormalities in heart failure,” International Heart Journal, vol. 56, no. 5, pp. 475–484, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Harada, T. Sugaya, K. Murakami, Y. Yazaki, and I. Komuro, “Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction,” Circulation, vol. 100, no. 20, pp. 2093–2099, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Basso, R. Cini, A. Pietrelli, L. Ferder, N. A. Terragno, and F. Inserra, “Protective effect of long-term angiotensin II inhibition,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 293, no. 3, pp. H1351–H1358, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Takada, S. Kinugawa, K. Hirabayashi et al., “Angiotensin II receptor blocker improves the lowered exercise capacity and impaired mitochondrial function of the skeletal muscle in type 2 diabetic mice,” Journal of Applied Physiology, vol. 114, no. 7, pp. 844–857, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Fukushima, S. Kinugawa, S. Takada et al., “Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from post-infarct heart failure in mice,” European Journal of Pharmacology, vol. 779, pp. 147–156, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Fukushima, S. Kinugawa, S. Takada et al., “(Pro)renin receptor in skeletal muscle is involved in the development of insulin resistance associated with postinfarct heart failure in mice,” American Journal of Physiology-Endocrinology and Metabolism, vol. 307, no. 6, pp. E503–E514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Yoshida and P. Delafontaine, “Mechanisms of cachexia in chronic disease states,” The American Journal of the Medical Sciences, vol. 350, no. 4, pp. 250–256, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Kadoguchi, S. Kinugawa, S. Takada et al., “Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle,” Experimental Physiology, vol. 100, no. 3, pp. 312–322, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. K. K. Griendling, C. A. Minieri, J. D. Ollerenshaw, and R. W. Alexander, “Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells,” Circulation Research, vol. 74, no. 6, pp. 1141–1148, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Ahn, A. W. Beharry, G. S. Frye, A. R. Judge, and L. F. Ferreira, “NAD(P)H oxidase subunit p47phox is elevated, and p47phox knockout prevents diaphragm contractile dysfunction in heart failure,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 309, no. 5, pp. L497–L505, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. L. R. G. Bechara, J. B. N. Moreira, P. R. Jannig et al., “NADPH oxidase hyperactivity induces plantaris atrophy in heart failure rats,” International Journal of Cardiology, vol. 175, no. 3, pp. 499–507, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. F. Cunha, L. R. G. Bechara, A. V. N. Bacurau et al., “Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats,” Journal of Applied Physiology, vol. 122, no. 4, pp. 817–827, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. D. I. Brown and K. K. Griendling, “Nox proteins in signal transduction,” Free Radical Biology & Medicine, vol. 47, no. 9, pp. 1239–1253, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Inoue, S. Kinugawa, T. Suga et al., “Angiotensin II-induced reduction in exercise capacity is associated with increased oxidative stress in skeletal muscle,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 302, no. 5, pp. H1202–H1210, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Ono, S. Takada, S. Kinugawa, and H. Tsutsui, “Curcumin ameliorates skeletal muscle atrophy in type 1 diabetic mice by inhibiting protein ubiquitination,” Experimental Physiology, vol. 100, no. 9, pp. 1052–1063, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Ohta, S. Kinugawa, S. Matsushima et al., “Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 5, pp. H1637–H1644, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Takada, K. Hirabayashi, S. Kinugawa et al., “Pioglitazone ameliorates the lowered exercise capacity and impaired mitochondrial function of the skeletal muscle in type 2 diabetic mice,” European Journal of Pharmacology, vol. 740, pp. 690–696, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Takada, S. Kinugawa, S. Matsushima et al., “Sesamin prevents decline in exercise capacity and impairment of skeletal muscle mitochondrial function in mice with high-fat diet-induced diabetes,” Experimental Physiology, vol. 100, no. 11, pp. 1319–1330, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Takada, Y. Masaki, S. Kinugawa et al., “Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling,” Cardiovascular Research, vol. 111, no. 4, pp. 338–347, 2016. View at Publisher · View at Google Scholar
  24. T. Suga, S. Kinugawa, S. Takada et al., “Combination of exercise training and diet restriction normalizes limited exercise capacity and impaired skeletal muscle function in diet-induced diabetic mice,” Endocrinology, vol. 155, no. 1, pp. 68–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Yokota, S. Kinugawa, K. Hirabayashi et al., “Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 297, no. 3, pp. H1069–H1077, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. C. Blendea, D. Jacobs, C. S. Stump et al., “Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression,” American Journal of Physiology-Endocrinology and Metabolism, vol. 288, no. 2, pp. E353–E359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Kackstein, A. Teren, Y. Matsumoto et al., “Impact of angiotensin II on skeletal muscle metabolism and function in mice: contribution of IGF-1, Sirtuin-1 and PGC-1α,” Acta Histochemica, vol. 115, no. 4, pp. 363–370, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. C. Bodine, E. Latres, S. Baumhueter et al., “Identification of ubiquitin ligases required for skeletal Muscle Atrophy,” Science, vol. 294, no. 5547, pp. 1704–1708, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Cho, J. L. Thorvaldsen, Q. Chu, F. Feng, and M. J. Birnbaum, “Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice,” The Journal of Biological Chemistry, vol. 276, no. 42, pp. 38349–38352, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Ohanna, A. K. Sobering, T. Lapointe et al., “Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control,” Nature Cell Biology, vol. 7, no. 3, pp. 286–294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Aguilar, S. Alliouachene, A. Sotiropoulos et al., “S6 Kinase Deletion Suppresses Muscle Growth Adaptations to Nutrient Availability by Activating AMP Kinase,” Cell Metabolism, vol. 5, no. 6, pp. 476–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. B. A. Clarke, D. Drujan, M. S. Willis et al., “The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle,” Cell Metabolism, vol. 6, no. 5, pp. 376–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Izumiya, T. Hopkins, C. Morris et al., “Fast/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice,” Cell Metabolism, vol. 7, no. 2, pp. 159–172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Shimizu, N. Yoshikawa, N. Ito et al., “Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle,” Cell Metabolism, vol. 13, no. 2, pp. 170–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. K. Bendall, A. C. Cave, C. Heymes, N. Gall, and A. M. Shah, “Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice,” Circulation, vol. 105, no. 3, pp. 293–296, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Wei, J. R. Sowers, R. Nistala et al., “Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells,” The Journal of Biological Chemistry, vol. 281, no. 46, pp. 35137–35146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. K. C. H. Fearon, D. J. Glass, and D. C. Guttridge, “Cancer cachexia: mediators, signaling, and metabolic pathways,” Cell Metabolism, vol. 16, no. 2, pp. 153–166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. A. U. Trendelenburg, A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama, and D. J. Glass, “Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size,” American Journal of Physiology-Cell Physiology, vol. 296, no. 6, pp. C1258–C1270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. B.-W. Wang, H. Chang, P. Kuan, and K.-G. Shyu, “Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway,” Journal of Endocrinology, vol. 197, no. 1, pp. 85–93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Gómez-Mauricio, I. Moscoso, M.-F. Martín-Cancho et al., “Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model,” Stem Cell Research & Therapy, vol. 7, no. 1, article no. 94, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. S. T. Russell, H. Eley, and M. J. Tisdale, “Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II,” Cellular Signalling, vol. 19, no. 8, pp. 1797–1806, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. L. C. Semprun-Prieto, S. Sukhanov, T. Yoshida et al., “Angiotensin II induced catabolic effect and muscle atrophy are redox dependent,” Biochemical and Biophysical Research Communications, vol. 409, no. 2, pp. 217–221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. Y.-P. Li, Y. Chen, A. S. Li, and M. B. Reid, “Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes,” American Journal of Physiology-Cell Physiology, vol. 285, no. 4, pp. C806–C812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Haegens, A. M. Schols, S. H. Gorissen et al., “NF-_κB activation and polyubiquitin conjugation are required for pulmonary inflammation-induced diaphragm atrophy,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 302, no. 1, pp. L103–L110, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Li, Y. Chen, J. John et al., “TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle,” The FASEB Journal, vol. 19, no. 3, pp. 362–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Mittal, S. Bhatnagar, A. Kumar et al., “The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice,” The Journal of Cell Biology, vol. 188, no. 6, pp. 833–849, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Li and Z. Li, “Neuroprotective effect of paeoniflorin on H2O2-induced apoptosis in PC12 cells by modulation of reactive oxygen species and the inflammatory response,” Experimental and Therapeutic Medicine, vol. 9, no. 5, pp. 1768–1772, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. J. D. Pollock, D. A. Williams, M. A. C. Gifford et al., “Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production,” Nature Genetics, vol. 9, no. 2, pp. 202–209, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Kinugawa, J. Zhang, E. Messina et al., “Gp91phox-containing NAD(P)H oxidase mediates attenuation of nitric oxide-dependent control of myocardial oxygen consumption by ANG II,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 2, pp. H862–H867, 2005. View at Publisher · View at Google Scholar · View at Scopus